Page last updated: 2024-08-18

cyclohexanol and glyceryl 2-arachidonate

cyclohexanol has been researched along with glyceryl 2-arachidonate in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.33)18.2507
2000's21 (70.00)29.6817
2010's8 (26.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itoh, K; Kondo, S; Nakane, S; Shinoda, A; Sugiura, T; Sukagawa, A; Waku, K; Yamashita, A1
Kishimoto, S; Kodaka, T; Kondo, S; Miyashita, T; Nakane, S; Sugiura, T; Suhara, Y; Takayama, H; Waku, K1
Fan, X; Gonsiorek, W; Hipkin, RW; Lundell, D; Lunn, C; Narula, S1
Campbell, WB; Edgemond, WS; Hillard, CJ; Jarrahian, A; Manna, S1
Darmani, NA1
Mannaioni, PF; Marzocca, C; Masini, E; Passani, MB; Pierpaoli, S; Vannacci, A; Zagli, G1
Bari, M; Finazzi-Agrò, A; Leeflang, BR; Maccarrone, M; van der Stelt, M; van Kuik, JA; van Zadelhoff, G; Veldink, GA; Vliegenthart, JF1
Del Giudice, E; Facchinetti, F; Furegato, S; Leon, A; Passarotto, M1
Barda, L; Blau, H; Cohen, V; Faigenboim, M; Foox, A; Fride, E; Mechoulam, R; Rosenberg, E1
Bari, M; Battista, N; Bernardi, G; Calabresi, P; Centonze, D; Finazzi-Agrò, A; Gubellini, P; Maccarrone, M; Picconi, B1
Alberich Jordà, M; Battista, N; Delwel, R; Löwenberg, B; Maccarrone, M; Rayman, N; Tas, M; van Lom, K; Verbakel, SE1
Gokoh, M; Kishimoto, S; Kobayashi, Y; Oka, S; Sugiura, T; Waku, K1
Di Felice, A; Fantappiè, O; Giannini, L; Mannaioni, PF; Masini, E; Mazzanti, R; Passani, MB; Pierpaoli, S; Vannacci, A; Zagli, G1
Adams, M; Cassar, S; Daza, A; Kage, K; Meyer, M; Mukherjee, S; Whiteaker, K; Yao, BB1
Joseph, BK; Mayeux, PR; Prather, PL; Ruckle, MB; Shoemaker, JL1
Mayeux, PR; Prather, PL; Ruckle, MB; Shoemaker, JL1
Hayase, T; Yamamoto, K; Yamamoto, Y1
Gorzalka, BB; Hill, MN; Hillard, CJ; Ho, WS; Meier, SE1
Hille, B; Lauckner, JE; Mackie, K1
Gokoh, M; Kishimoto, S; Oka, S; Sugiura, T; Wakui, J1
Scutt, A; Williamson, EM1
Carrier, EJ; Gorzalka, BB; Hill, MN; Hillard, CJ; Ho, WS; Patel, S; Shi, L1
Clapper, JR; Eisenstein, SA; Hohmann, AG; Holmes, PV; Piomelli, D1
Avraham, HK; Avraham, S; Banu, N; Fu, Y; Groopman, JE; Jiang, S; Jorda, MA; Makriyannis, A; Parmar, K; Williams, JS; Wood, JA; Zagozdzon, R1
Chiba, T; Nakahata, N; Obara, Y; Ueno, S1
Abdullah, R; Cravatt, BF; Kinsey, SG; Lichtman, AH; Ramesh, D; Selley, DE; Wise, LE1
Feliszek, M; Ilayan, E; Malinowska, B; Schlicker, E1
Cipriano, M; Fowler, CJ; Gouveia-Figueira, S; Nording, M; Persson, E1
Bagher, AM; Denovan-Wright, EM; Dupré, DJ; Kelly, ME; Laprairie, RB1
Bedse, G; Gaulden, AD; Hartley, ND; Kingsley, PJ; Marnett, LJ; Neale, E; Patel, S; Patrick, TA; Plath, N; Uddin, MJ1

Other Studies

30 other study(ies) available for cyclohexanol and glyceryl 2-arachidonate

ArticleYear
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
    Biochemical and biophysical research communications, 1995, Oct-04, Volume: 215, Issue:1

    Topics: Animals; Arachidonic Acids; Binding, Competitive; Brain; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Lipase; Male; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Synaptic Membranes; Tritium

1995
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.
    The Journal of biological chemistry, 2000, Jan-07, Volume: 275, Issue:1

    Topics: Amides; Arachidonic Acids; Calcium Signaling; Camphanes; Cannabinoids; Cyclohexanols; Cyclooxygenase Inhibitors; Drug Interactions; Endocannabinoids; Ethanolamines; Glycerides; HL-60 Cells; Humans; Ligands; Lipoxygenase Inhibitors; Molecular Mimicry; Palmitic Acids; Pertussis Toxin; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; RNA, Messenger; Structure-Activity Relationship; Virulence Factors, Bordetella

2000
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Molecular pharmacology, 2000, Volume: 57, Issue:5

    Topics: Animals; Arachidonic Acids; Binding, Competitive; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Drug Antagonism; Endocannabinoids; Glycerides; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Immunosuppressive Agents; Insecta; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Sulfur Radioisotopes; Transfection

2000
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.
    Journal of neurochemistry, 2000, Volume: 74, Issue:6

    Topics: Adjuvants, Immunologic; Amidohydrolases; Animals; Arachidonic Acids; Binding, Competitive; Biological Transport; Cannabinoid Receptor Modulators; Cannabinoids; Carrier Proteins; Cells, Cultured; Cerebellum; Cyclohexanols; Endocannabinoids; Glycerides; Immunosuppressive Agents; Ligands; Neurons; Polyunsaturated Alkamides; Prosencephalon; Rats; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Tritium

2000
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:1

    Topics: Animals; Antiemetics; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Emetics; Endocannabinoids; Female; Glycerides; Humans; Male; Motor Activity; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews

2002
Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2002, Volume: 51 Suppl 1

    Topics: Animals; Antigens, CD; Arachidonic Acids; Basophils; Camphanes; Cannabinoids; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Guinea Pigs; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Macrophage Activation; Mast Cells; Platelet Membrane Glycoproteins; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Tetraspanin 30

2002
Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Binding, Competitive; Biological Transport; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Carrier Proteins; Chloroform; Cyclohexanols; Endocannabinoids; Glycerides; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Molecular Conformation; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Tumor Cells, Cultured; Water

2002
Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
    Glia, 2003, Jan-15, Volume: 41, Issue:2

    Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Arachidonic Acids; Benzoxazines; Brain; Cannabinoids; Cells, Cultured; Cyclohexanols; Dronabinol; Encephalitis; Endocannabinoids; Glycerides; Inflammation Mediators; Microglia; Morpholines; Naphthalenes; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Tumor Necrosis Factor-alpha

2003
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    European journal of pharmacology, 2003, Feb-07, Volume: 461, Issue:1

    Topics: Animals; Animals, Newborn; Animals, Suckling; Arachidonic Acids; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Modulators; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Endocannabinoids; Female; Glycerides; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Milk; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Survival Rate; Time Factors

2003
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.
    Journal of neurochemistry, 2003, Volume: 85, Issue:4

    Topics: Amidohydrolases; Animals; Antiparkinson Agents; Arachidonic Acids; Binding, Competitive; Cannabinoid Receptor Modulators; Cerebellum; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Endocannabinoids; Excitatory Postsynaptic Potentials; Fatty Acids, Unsaturated; Glutamic Acid; Glycerides; In Vitro Techniques; Levodopa; Oxidopamine; Parkinsonian Disorders; Patch-Clamp Techniques; Phospholipase D; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug

2003
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
    Blood, 2004, Jul-15, Volume: 104, Issue:2

    Topics: Acute Disease; Arachidonic Acids; Bucladesine; Cannabinoid Receptor Modulators; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ligands; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neutrophils; Pertussis Toxin; Receptor, Cannabinoid, CB2; Receptors, Granulocyte Colony-Stimulating Factor

2004
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.
    Journal of biochemistry, 2004, Volume: 135, Issue:4

    Topics: Arachidonic Acid; Arachidonic Acids; Blotting, Northern; Calcitriol; Camphanes; Cell Differentiation; Chemokine CCL2; Chemokines; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme-Linked Immunosorbent Assay; Gene Expression; Glycerides; HL-60 Cells; Humans; Interleukin-8; Lipopolysaccharides; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB2; RNA, Messenger; Time Factors

2004
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:1

    Topics: Animals; Arachidonic Acids; Blotting, Western; Cannabinoid Receptor Modulators; Cyclohexanols; Eicosanoids; Endocannabinoids; Enzyme Inhibitors; Glycerides; Guinea Pigs; Immunity; Immunosuppressive Agents; Male; Mast Cells; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptor, Cannabinoid, CB2

2004
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors.
    European journal of pharmacology, 2004, Nov-28, Volume: 505, Issue:1-3

    Topics: Animals; Arachidonic Acids; Benzoxazines; Binding, Competitive; Calcium; Cell Line; Chromones; Colforsin; Cyclic AMP; Cyclohexanols; DNA, Complementary; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Humans; Indoles; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Species Specificity; Transfection; Tritium

2004
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:2

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Analgesics; Animals; Arachidonic Acids; Binding, Competitive; Biotransformation; CHO Cells; Cricetinae; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Enzyme Inhibitors; Glycerides; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); HL-60 Cells; Humans; In Vitro Techniques; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, G-Protein-Coupled; Transfection

2005
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2

    Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Binding, Competitive; Blotting, Western; Calcium Signaling; Cannabinoid Receptor Modulators; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Cyclohexanols; DNA, Complementary; Endocannabinoids; Enzyme-Linked Immunosorbent Assay; Glycerides; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Indoles; Mitogen-Activated Protein Kinases; Receptor, Cannabinoid, CB2; Transfection

2005
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
    Behavioural pharmacology, 2005, Volume: 16, Issue:5-6

    Topics: Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Cannabinoids; Cocaine; Cyclohexanols; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Endocannabinoids; Glycerides; Injections, Intraperitoneal; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred ICR; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Time Factors

2005
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala.
    European journal of pharmacology, 2005, Dec-28, Volume: 528, Issue:1-3

    Topics: Amygdala; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Corticosterone; Cyclohexanols; Endocannabinoids; Glycerides; Male; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Signal Transduction

2005
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Dec-27, Volume: 102, Issue:52

    Topics: Analgesics; Animals; Arachidonic Acids; Benzoxazines; Calcium; Cannabinoids; Cell Line; Cyclohexanols; Cytoplasm; DNA, Complementary; Dronabinol; Endocannabinoids; Endoplasmic Reticulum; Excitatory Amino Acid Antagonists; Fluorescent Dyes; Fura-2; Glycerides; GTP-Binding Protein alpha Subunits, Gq-G11; Hippocampus; Humans; Immunosuppressive Agents; Morpholines; Naphthalenes; Neurons; Pertussis Toxin; Piperidines; Protein Binding; Protein Conformation; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Ryanodine; Time Factors; Type C Phospholipases

2005
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol.
    European journal of pharmacology, 2006, May-24, Volume: 538, Issue:1-3

    Topics: Administration, Cutaneous; Animals; Arachidonic Acids; Benzoxazines; Calcium; Cannabinoid Receptor Agonists; Cannabinoids; Cell Movement; Cyclohexanols; Dose-Response Relationship, Drug; Ear, External; Endocannabinoids; Glycerides; HL-60 Cells; Humans; Inflammation; Intracellular Fluid; Leukocytes; Ligands; Male; Mice; Mice, Inbred ICR; Morpholines; Naphthalenes; Peroxidase; Tetradecanoylphorbol Acetate

2006
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
    Calcified tissue international, 2007, Volume: 80, Issue:1

    Topics: Animals; Arachidonic Acids; Benzoxazines; Bone Marrow Cells; Cannabinoid Receptor Modulators; Cannabinoids; Cells, Cultured; Colony-Forming Units Assay; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Indomethacin; Male; Mesenchymal Stem Cells; Morpholines; Naphthalenes; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stem Cells

2007
Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus.
    Hippocampus, 2008, Volume: 18, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acids; Corticosterone; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Hippocampus; Immunosuppressive Agents; Male; Polyunsaturated Alkamides; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Tritium

2008
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.
    Pharmacological research, 2010, Volume: 61, Issue:5

    Topics: Animals; Arachidonic Acids; Autoradiography; Cannabinoid Receptor Modulators; Chromatography, High Pressure Liquid; Cyclohexanols; Densitometry; Dopamine; Endocannabinoids; Environment; Glycerides; Limbic System; Lipid Metabolism; Male; Mass Spectrometry; Motor Activity; Olfactory Bulb; Piperidines; Pyrazoles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction

2010
Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment.
    The Journal of biological chemistry, 2010, Nov-12, Volume: 285, Issue:46

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Blotting, Western; Bone Marrow Cells; Cannabinoid Receptor Modulators; Cell Communication; Cell Movement; Cells, Cultured; Cyclohexanols; Endocannabinoids; Female; Flow Cytometry; Glycerides; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Side-Population Cells; Stem Cell Niche; Stromal Cells

2010
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    The Journal of pharmacy and pharmacology, 2011, Volume: 63, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acids; Calcium; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Cannabinoids; Cerebellum; Cyclohexanols; Cytokines; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Inflammation; Lipopolysaccharides; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2011
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:3

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Benzodioxoles; Brain Chemistry; Cyclohexanols; Diclofenac; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Endocannabinoids; Glycerides; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stomach Ulcer; Substance Withdrawal Syndrome; Substance-Related Disorders

2013
Do cannabinoids exhibit a tyramine-like effect?
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Animals; Arachidonic Acids; Benzoxazines; Cannabidiol; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Glycerides; Kidney Cortex; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Time Factors; Tyramine

2013
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.
    BMC research notes, 2014, Jul-10, Volume: 7

    Topics: Arachidonic Acids; Benzodioxoles; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Cyclohexanols; Endocannabinoids; Enzyme Inhibitors; ErbB Receptors; Ethanolamines; Gene Expression Regulation, Neoplastic; Glycerides; Humans; Male; Monoacylglycerol Lipases; Piperidines; Polyunsaturated Alkamides; Prostate; Receptor, Cannabinoid, CB1; Signal Transduction

2014
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    The Journal of biological chemistry, 2014, Sep-05, Volume: 289, Issue:36

    Topics: Animals; Arachidonic Acids; Arrestin; Benzoxazines; Blotting, Western; Cannabinoid Receptor Agonists; Cannabinoids; Cells, Cultured; Corpus Striatum; Cyclohexanols; Dendritic Spines; Dronabinol; Endocannabinoids; Fluorescence Resonance Energy Transfer; Glycerides; GTP-Binding Proteins; Ligands; Luminescent Proteins; Mice; Models, Biological; Morpholines; Naphthalenes; Neurons; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Signal Transduction

2014
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.
    Biological psychiatry, 2017, Oct-01, Volume: 82, Issue:7

    Topics: Adaptation, Ocular; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzodioxoles; Brain; Cannabinoid Receptor Agonists; Cyclohexanols; Disease Models, Animal; Dronabinol; Endocannabinoids; Excitatory Postsynaptic Potentials; Glycerides; Heterocyclic Compounds, 1-Ring; Locomotion; Male; Mice; Mice, Inbred ICR; Piperidines; Polyunsaturated Alkamides; Pyridines; Signal Transduction

2017